Literature DB >> 3234638

Urinary excretion of 1,5-anhydro-D-glucitol accompanying glucose excretion in diabetic patients.

Y Akanuma1, M Morita, N Fukuzawa, T Yamanouchi, H Akanuma.   

Abstract

The urinary excretion of 1,5-anhydro-D-glucitol, a pyranoid polyol, in humans was studied. The plasma of nondiabetic human subjects contained high concentrations of this polyol (greater than 110 mumol/l), and there was a tendency for the 24-h excretion of it to become more variable in direct proportion to its plasma concentration. In contrast, diabetic patients showed lower plasma concentrations of this polyol, and the variation in the 24-h excretion of 1,5-anhydro-D-glucitol was especially notable among the patients with an extremely low plasma concentration of the polyol. This diabetic group showed a statistically significant correlation (p less than 0.01), between the urinary 1,5-anhydro-D-glucitol and urinary glucose. This correlation was more markedly demonstrated during a 100-g oral glucose tolerance test: parallel changes were observed in the concentrations of 1,5-anhydro-D-glucitol and glucose in the urine collected every hour after the glucose load. These observations led to the proposal that low plasma concentration of this polyol, which is observed in diabetes mellitus, may be the result of a frequent and/or prolonged high blood glucose concentration beyond the renal threshold for glucose excretion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3234638     DOI: 10.1007/bf00277486

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

1.  The active transport of sugars by various preparations of hamster intestine.

Authors:  R K CRANE; P MANDELSTAM
Journal:  Biochim Biophys Acta       Date:  1960-12-18

2.  Polyols in the cerebrospinal fluid and plasma of neurological, diabetic and uraemic patients.

Authors:  C Servo; J Palo; E Pitkänen
Journal:  Acta Neurol Scand       Date:  1977-08       Impact factor: 3.209

3.  Occurrence of I,5-anhydroglucitol in human cerebrospinal fluid.

Authors:  E Pitkänen
Journal:  Clin Chim Acta       Date:  1973-10-12       Impact factor: 3.786

4.  Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients.

Authors:  T Yamanouchi; H Akanuma; T Nakamura; I Akaoka; Y Akanuma
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

5.  Variation in polyol levels in cerebrospinal fluid and serum in diabetic patients.

Authors:  C Servo; E Pitkänen
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

6.  Reduced levels of plasma 1,5-anhydroglucitol in diabetic patients.

Authors:  H Akanuma; K Ogawa; Y Lee; Y Akanuma
Journal:  J Biochem       Date:  1981-07       Impact factor: 3.387

7.  Marked depletion of plasma 1,5-anhydroglucitol, a major polyol, in streptozocin-induced diabetes in rats and the effect of insulin treatment.

Authors:  T Yamanouchi; H Akanuma; F Takaku; Y Akanuma
Journal:  Diabetes       Date:  1986-02       Impact factor: 9.461

8.  Reduced renal reabsorption of 1,5-anhydro-D-glucitol in diabetic rats and mice.

Authors:  S Kametani; Y Hashimoto; T Yamanouchi; Y Akanuma; H Akanuma
Journal:  J Biochem       Date:  1987-12       Impact factor: 3.387

9.  Identification and metabolic implication of 1-deoxyglucose (1,5-anhydroglucitol) in human plasma.

Authors:  S Yoshioka; S Saitoh; T Fujisawa; A Fujimori; O Takatani; M Funabashi
Journal:  Clin Chem       Date:  1982-06       Impact factor: 8.327

10.  Variations of 1-deoxyglucose(1,5-anhydroglucitol) content in plasma from patients with insulin-dependent diabetes mellitus.

Authors:  S Yoshioka; S Saitoh; C Negishi; T Fujisawa; A Fujimori; O Takatani; M Imura; M Funabashi
Journal:  Clin Chem       Date:  1983-07       Impact factor: 8.327

View more
  18 in total

Review 1.  Utility of different glycemic control metrics for optimizing management of diabetes.

Authors:  Klaus-Dieter Kohnert; Peter Heinke; Lutz Vogt; Eckhard Salzsieder
Journal:  World J Diabetes       Date:  2015-02-15

2.  Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease.

Authors:  Casey M Rebholz; Morgan E Grams; Yuan Chen; Alden L Gross; Yingying Sang; Josef Coresh; Elizabeth Selvin
Journal:  Am J Epidemiol       Date:  2017-10-15       Impact factor: 4.897

3.  Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial.

Authors:  S P Juraschek; E R Miller; L J Appel; R H Christenson; F M Sacks; E Selvin
Journal:  Diabet Med       Date:  2017-07-09       Impact factor: 4.359

4.  Conditional synthesis and utilization of 1,5-anhydroglucitol in Escherichia coli.

Authors:  Y Shiga; H Mizuno; H Akanuma
Journal:  J Bacteriol       Date:  1993-11       Impact factor: 3.490

5.  Metabolite profiling in plasma and tissues of ob/ob and db/db mice identifies novel markers of obesity and type 2 diabetes.

Authors:  Pieter Giesbertz; Inken Padberg; Dietrich Rein; Josef Ecker; Anja S Höfle; Britta Spanier; Hannelore Daniel
Journal:  Diabetologia       Date:  2015-06-10       Impact factor: 10.122

6.  A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China.

Authors:  Y Wang; Y L Zhang; Y P Wang; C H Lei; Z L Sun
Journal:  Diabetes Metab Res Rev       Date:  2012-05       Impact factor: 4.876

7.  Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction.

Authors:  Won Jun Kim; Cheol-Young Park; Kyu-Beck Lee; Se Eun Park; Eun Jung Rhee; Won Young Lee; Ki Won Oh; Sung Woo Park
Journal:  Diabetes Care       Date:  2011-12-30       Impact factor: 19.112

8.  Effect of mulberry leaf extract with enriched 1-deoxynojirimycin content on postprandial glycemic control in subjects with impaired glucose metabolism.

Authors:  Akira Asai; Kiyotaka Nakagawa; Ohki Higuchi; Toshiyuki Kimura; Yoshihiro Kojima; Jun Kariya; Teruo Miyazawa; Shinichi Oikawa
Journal:  J Diabetes Investig       Date:  2011-08-02       Impact factor: 4.232

9.  Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.

Authors:  Aparna Pal; Andrew J Farmer; Christina Dudley; Mary P Selwood; Beryl A Barrow; Rhiannon Klyne; Jilly P Grew; Mark I McCarthy; Anna L Gloyn; Katharine R Owen
Journal:  Diabetes Care       Date:  2009-11-23       Impact factor: 19.112

10.  Association of time in range with hemoglobin A1c, glycated albumin and 1,5-anhydro-d-glucitol.

Authors:  Mana Ohigashi; Keiko Osugi; Yoshiki Kusunoki; Kahori Washio; Satoshi Matsutani; Taku Tsunoda; Toshihiro Matsuo; Kosuke Konishi; Tomoyuki Katsuno; Mitsuyoshi Namba; Hidenori Koyama
Journal:  J Diabetes Investig       Date:  2020-11-15       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.